Reviews - 4oq3 mentioned but not cited (1)
- How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures. Estrada-Ortiz N, Neochoritis CG, Dömling A. ChemMedChem 11 757-772 (2016)
Articles - 4oq3 mentioned but not cited (4)
- Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening. Atatreh N, Ghattas MA, Bardaweel SK, Rawashdeh SA, Sorkhy MA. Drug Des Devel Ther 12 3741-3752 (2018)
- Potential use of compounds from sea cucumbers as MDM2 and CXCR4 inhibitors to control cancer cell growth. Wargasetia TL, Permana S, Widodo N. Exp Ther Med 16 2985-2991 (2018)
- Rationally Designed Polypharmacology: α-Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl-1 and HDM2. Conlon IL, Drennen B, Lanning ME, Hughes S, Rothhaas R, Wilder PT, MacKerell AD, Fletcher S. ChemMedChem 15 1691-1698 (2020)
- Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents. Li BH, Ge JQ, Wang YL, Wang LJ, Zhang Q, Bian C. Comput Math Methods Med 2021 3195957 (2021)
Reviews citing this publication (4)
- Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives. Fang Y, Liao G, Yu B. Acta Pharm Sin B 10 1253-1278 (2020)
- Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction. Beloglazkina A, Zyk N, Majouga A, Beloglazkina E. Molecules 25 E1211 (2020)
- Chemical Variations on the p53 Reactivation Theme. Ribeiro CJ, Rodrigues CM, Moreira R, Santos MM. Pharmaceuticals (Basel) 9 E25 (2016)
- Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting. Tan YS, Mhoumadi Y, Verma CS. J Mol Cell Biol 11 306-316 (2019)
Articles citing this publication (5)
- Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. Furet P, Masuya K, Kallen J, Stachyra-Valat T, Ruetz S, Guagnano V, Holzer P, Mah R, Stutz S, Vaupel A, Chène P, Jeay S, Schlapbach A. Bioorg Med Chem Lett 26 4837-4841 (2016)
- Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53-MDM2 interaction with a distinct binding mode. Gessier F, Kallen J, Jacoby E, Chène P, Stachyra-Valat T, Ruetz S, Jeay S, Holzer P, Masuya K, Furet P. Bioorg Med Chem Lett 25 3621-3625 (2015)
- Controllable access to multi-substituted imidazoles via palladium(ii)-catalyzed C-C coupling and C-N condensation cascade reactions. Yu H, Xiao L, Yang X, Shao L. Chem Commun (Camb) 53 9745-9748 (2017)
- Inhibiting mechanism of small molecule toward the p53-MDM2 interaction: A molecular dynamic exploration. Chen J, Wang J, Pang L, Zhu W. Chem Biol Drug Des 92 1763-1777 (2018)
- Promising anticancer activity of batumin: a natural polyene antibiotic produced by Pseudomonas batumici. Soldatkina MA, Klochko VV, Zagorodnya SD, Rademan S, Visagie MH, Lebelo MT, Gwangwa MV, Joubert AM, Lall N, Reva ON. Future Med Chem 10 2187-2199 (2018)